ASTEAR SEMAIE: Open Payments
NPI 1700513710 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,641 in 60 payments from 16 companies in 2025. Trend: 2023 $60 · 2024 $985 · 2025 $1,641
Food & beverage: $1,556Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $422 |
| ABBVIE INC. | 15 | $308 |
| Madrigal Pharmaceuticals | 4 | $234 |
| QOL Medical, LLC | 5 | $137 |
| PFIZER INC. | 4 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $90 |
| GENZYME CORPORATION | 3 | $70 |
| Lilly USA, LLC | 3 | $70 |
| Daiichi Sankyo Inc. | 2 | $44 |
| Alnylam Pharmaceuticals Inc. | 2 | $35 |
Products named: TREMFYA, REZDIFFRA, RINVOQ, Sucraid, ENTYVIO, VELSIPITY, DUPIXENT, SKYRIZI.
Industry payments across MD — which companies pay providers there.
